SPXL TQQQ: Stability Tech-Focused ETF Choices for Investors
If you want amplified daily moves, SPXL and TQQQ offer two very different paths. This guide breaks down costs, risk, ...
Articles — Page 253
Infrastructure Stock This Past Draws a New $6M Investment
The infrastructure sector kept surprising investors as new capital flowed into leading contractors. This past year sa...
Imax Sold Shares Worth: CEO Stock Move Explained
When a CEO sells a sizable block of stock, investors take notice. This article breaks down the numbers behind imax so...
Maxed Your IRA? Here's What Comes Next for Your Savings
You’ve hit the IRA max. Now what? This practical guide lays out clear steps, tax-smart options, and real-world scenar...
Better Nuclear Energy Stock: Oklo vs Centrus Energy
Two rising names—Oklo and Centrus Energy—are shaping the future of U.S. nuclear energy. This guide breaks down which ...
Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Meet Discount Retailer Stacking: How Monster Comps Live On
A discount retailer is stacking double-digit comps on top of double-digit comps. This article breaks down what that m...
Target Cutting Prices 3,000 Items: Inflation's Pain Point?
Inflation is pushing shoppers to hunt for value, and Target is answering with a broad price-cut program on 3,000 item...
China’s Power ‘Supergrid’ Gives Buffers Against Shocks
China accelerates grid expansion to channel renewables and cut imports, a move shaping energy costs and bond markets ...
Airline CEOs Plead with Congress to Restore DHS Funding
Major U.S. carriers push lawmakers to fund DHS and guarantee wages for frontline workers amid a partial government sh...
Inherited 2026? 10-Year Rule and Your IRA Strategy
When a loved one passes, you may inherit an IRA with rules you must follow. By 2026, the 10-year rule continues to sh...
Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...